Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Peripheral T-cell lymphomas (PTCL) are a rare, aggressive group of hematological malignancies originating from mature T-cells.
• PTCL represent less than 15% of adult non-Hodgkin's lymphomas (NHL) and are often diagnosed at advanced stages.
• The 'unspecified variant' (PTCL-U) is the most common subtype, characterized by aggressive clinical behavior.

Purpose of the Study:

• To review the pathobiological aspects of PTCL.
• To describe the clinical characteristics and current therapeutic strategies for PTCL.
• To provide special attention to the PTCL-unspecified (PTCL-U) subtype.

Main Methods:

• Literature review of pathobiology, clinical presentation, and treatment of PTCL.
• Analysis of current WHO classification of PTCL subtypes.
• Focus on PTCL-U as the most prevalent subtype.

Main Results:

• PTCL are heterogeneous and aggressive, often presenting late.
• PTCL-U is the most common subtype requiring prompt treatment.
• Understanding PTCL biology is crucial for developing new therapies.

Conclusions:

• PTCL, particularly PTCL-U, present significant therapeutic challenges due to their aggressive nature and rarity.
• Further research into PTCL biology is essential for improving patient outcomes.
• Current therapeutic strategies require optimization for better management of these lymphomas.